Trial NCT01701063

View at ClinicalTrials.gov 
Org. Study IDs: VX11-950-118

Last trial update was posted on 2016-07-20

MeSH Interventions

Peginterferon alfa-2b Ribavirin

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Study was terminated early because it was determined that telaprevir/Peg-IFN/RBV regimen did not present a meaningful therapeutic treatment over existing interferon-free regimens and was unlikely to be used for participants aged 3 to 17 years.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID